Latest / Science News Today | 2 Min News | The Daily News Now!
Weight Loss Drugs and Insurance Realities | Science News
New weight loss drugs like Ozempic and Wegovy are revolutionizing obesity treatment, but insurers are stuck in a cost crunch. While studies prove their health benefits, covering even a fraction of users could hit insurance budgets with over $800 million. The promise? Preventing future health costs by tackling obesity early. But here’s the catch: long-term data is lacking, and most patients quit within a year—often due to cost or side effects—leading to weight regain. For insurers to see real savings, patients need sustained support: dietitians, gym access, and lifestyle coaching. Without that…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.